Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance.
about
Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics.Simultaneous Spectrophotometric Method for Determination of Emtricitabine and Tenofovir Disoproxil Fumarate in Three-Component Tablet Formulation Containing Rilpivirine Hydrochloride.Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms.HPLC method for the determination of emtricitabine and related degradation substances.Synthesis and evaluation of molecularly imprinted polymeric microspheres for highly selective extraction of an anti-AIDS drug emtricitabine.A Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Tenofovir, Emtricitabine, and a Efavirenz and Statistical Approach to Determine the Effect of VariablesSimple Spectrophotometric Methods for Determination of Tenofovir Fumarate and Emtricitabine in Bulk Powder and in Tablets
P2860
Q41218781-EFA2EF57-7007-4A3C-9545-2A5393D0BBA9Q41871402-5DD67C42-C4EE-4AFD-9F7B-C84AFF2221C5Q42575236-FA81F75A-0239-463F-AB7F-9B5C3CF111B5Q43438728-2345C4AC-752B-466C-8099-240BFFE4DD5EQ45929804-D034008F-F0C8-4561-83D4-F6386FE98AE8Q59000214-0D0167F2-5B04-4BA1-BAEE-A2DF99687F93Q59021211-83981D38-5E10-447A-B060-103D1CD16862
P2860
Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Development and validation of ...... mpounds in the drug substance.
@en
Development and validation of ...... mpounds in the drug substance.
@nl
type
label
Development and validation of ...... mpounds in the drug substance.
@en
Development and validation of ...... mpounds in the drug substance.
@nl
prefLabel
Development and validation of ...... mpounds in the drug substance.
@en
Development and validation of ...... mpounds in the drug substance.
@nl
P2093
P356
P1476
Development and validation of ...... mpounds in the drug substance.
@en
P2093
Ann Verbeek
Dunge Ashenafi
Erwin Adams
Jos Hoogmartens
P304
P356
10.1002/JSSC.200800688
P577
2009-06-01T00:00:00Z